RhumbLine Advisers

RhumbLine Advisers’s Icosavax, Inc. Common Stock ICVX Stock Holding History

RhumbLine Advisers’s Portfolio ICVX Stock Details ICVX Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell
2023 Q4	$670K	Buy
2023 Q3	$316K	Buy
2023 Q2	$391K	Buy
2023 Q1	$201K	Buy
2022 Q4	$270K	Buy
2022 Q3	$103K	Buy
2022 Q2	$177K	Buy
2022 Q1	$143K	Buy
2021 Q4	$281K	Buy
2021 Q3	$356K	Buy